Column Capital Advisors’s Biodesix BDSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDSX
ACM
OM
Column Capital Advisors's BDSX Position: Q3 2023 in Review
Column Capital Advisors held its Biodesix (BDSX) position steady in Q3 2023 at 285 shares worth $9.4K. The position accounts for ﹤0.01% of the portfolio, ranked #528.
Column Capital Advisors first reported a position in BDSX in Q3 2021 and has held it in 9 quarters since. The position peaked at $23K in Q3 2021. 37 funds tracked by Wall St. Rank hold BDSX as of Q3 2023.
- Column Capital Advisors held 285 shares of Biodesix worth $9.4K as of Q3 2023.
- Column Capital Advisors left its Biodesix share count unchanged in Q3 2023.
- Biodesix made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #528 holding.
- Column Capital Advisors first reported a position in Biodesix in Q3 2021 and has held it in 9 quarters since.
- Column Capital Advisors's Biodesix position peaked at $23K in Q3 2021.
- 37 funds tracked by Wall St. Rank held Biodesix as of Q3 2023.
Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.